Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Chemical Society Reviews
|
February 8, 2011
Boron-containing inhibitors of synthetases
Stephen J Baker, John W Tomsho, Stephen J Benkovic
International Journal of Oral Science
|
January 31, 2015
Lipopolysaccharide inhibits or accelerates biomedical titanium corrosion depending on environmental acidity
Fei Yu, Owen Addison, Stephen J Baker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2018
Technologies to address antimicrobial resistance
Stephen J Baker, David J Payne, Rino Rappuoli, et al.
Expert Opinion on Investigational Drugs
|
January 25, 2007
Recent progress on the topical therapy of onychomycosis
Michael R K Alley, Stephen J Baker, Karl R Beutner, et al.
Future Medicinal Chemistry
|
March 24, 2011
Therapeutic potential of boron-containing compounds
Stephen J Baker, Charles Z Ding, Tsutomu Akama, et al.
The Science of the Total Environment
|
June 3, 2015
The PM10 fraction of road dust in the UK and India: Characterization, source profiles and oxidative potential
Pallavi Pant, Stephen J Baker, Anuradha Shukla, et al.
Journal of Molecular Biology
|
May 12, 2009
Crystal structures of the human and fungal cytosolic Leucyl-tRNA synthetase editing domains: A structural basis for the rational design of antifungal benzoxaboroles
Elena Seiradake, Weimin Mao, Vincent Hernandez, et al.
Research Report (Health Effects Institute)
|
December 17, 2009
Measurement and modeling of exposure to selected air toxics for health effects studies and verification by biomarkers
Roy M Harrison, Juana Maria Delgado-Saborit, Stephen J Baker, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 24, 2009
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis
Tsutomu Akama, Stephen J Baker, Yong-Kang Zhang, et al.
Journal of Medicinal Chemistry
|
July 21, 2006
Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis
Stephen J Baker, Yong-Kang Zhang, Tsutomu Akama, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Chemical Society Reviews
|
February 8, 2011
Boron-containing inhibitors of synthetases
Stephen J Baker, John W Tomsho, Stephen J Benkovic
International Journal of Oral Science
|
January 31, 2015
Lipopolysaccharide inhibits or accelerates biomedical titanium corrosion depending on environmental acidity
Fei Yu, Owen Addison, Stephen J Baker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2018
Technologies to address antimicrobial resistance
Stephen J Baker, David J Payne, Rino Rappuoli, et al.
Expert Opinion on Investigational Drugs
|
January 25, 2007
Recent progress on the topical therapy of onychomycosis
Michael R K Alley, Stephen J Baker, Karl R Beutner, et al.
Future Medicinal Chemistry
|
March 24, 2011
Therapeutic potential of boron-containing compounds
Stephen J Baker, Charles Z Ding, Tsutomu Akama, et al.
The Science of the Total Environment
|
June 3, 2015
The PM10 fraction of road dust in the UK and India: Characterization, source profiles and oxidative potential
Pallavi Pant, Stephen J Baker, Anuradha Shukla, et al.
Journal of Molecular Biology
|
May 12, 2009
Crystal structures of the human and fungal cytosolic Leucyl-tRNA synthetase editing domains: A structural basis for the rational design of antifungal benzoxaboroles
Elena Seiradake, Weimin Mao, Vincent Hernandez, et al.
Research Report (Health Effects Institute)
|
December 17, 2009
Measurement and modeling of exposure to selected air toxics for health effects studies and verification by biomarkers
Roy M Harrison, Juana Maria Delgado-Saborit, Stephen J Baker, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 24, 2009
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis
Tsutomu Akama, Stephen J Baker, Yong-Kang Zhang, et al.
Journal of Medicinal Chemistry
|
July 21, 2006
Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosis
Stephen J Baker, Yong-Kang Zhang, Tsutomu Akama, et al.
Page
of 3